Michigan Team February, 2005. Amy Wagaman Bibhas Chakraborty Herle McGowan Susan Murphy Lacey Gunter Danny Almirall Anne Buu.

Slides:



Advertisements
Similar presentations
Assessing the Effects of Time-varying Predictors or Treatments: A Conceptual Discussion Daniel Almirall VA Medical Center, HSRD Duke Medical Center, Dept.
Advertisements

Treatment Effect Heterogeneity & Dynamic Treatment Regime Development S.A. Murphy.
Experimenting to Improve Clinical Practice S.A. Murphy AAAS, 02/15/13 TexPoint fonts used in EMF. Read the TexPoint manual before you delete this box.:
1 Developing Dynamic Treatment Regimes for Chronic Disorders S.A. Murphy Univ. of Michigan RAND: August, 2005.
1 Developing Adaptive Treatment Strategies using MOST Experimental Designs S.A. Murphy Univ. of Michigan Dallas: December, 2005.
Methodology for Adaptive Treatment Strategies for Chronic Disorders: Focus on Pain S.A. Murphy NIH Pain Consortium 5 th Annual Symposium on Advances in.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan JSM: August, 2005.
SMART Designs for Constructing Adaptive Treatment Strategies S.A. Murphy 15th Annual Duke Nicotine Research Conference September, 2009.
Substance Abuse, Multi-Stage Decisions, Generalization Error How are they connected?! S.A. Murphy Univ. of Michigan CMU, Nov., 2004.
An Experimental Paradigm for Developing Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan March, 2004.
Constructing Dynamic Treatment Regimes & STAR*D S.A. Murphy ICSA June 2008.
Screening Experiments for Developing Dynamic Treatment Regimes S.A. Murphy At ICSPRAR January, 2008.
SMART Designs for Developing Adaptive Treatment Strategies S.A. Murphy K. Lynch, J. McKay, D. Oslin & T.Ten Have CPDD June, 2005.
Dynamic Treatment Regimes: Challenges in Data Analysis S.A. Murphy Survey Research Center January, 2009.
Sizing a Trial for the Development of Adaptive Treatment Strategies Alena I. Oetting The Society for Clinical Trials, 29th Annual Meeting St. Louis, MO.
Screening Experiments for Dynamic Treatment Regimes S.A. Murphy At ENAR March, 2008.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan Florida: January, 2006.
SMART Experimental Designs for Developing Adaptive Treatment Strategies S.A. Murphy NIDA DESPR February, 2007.
Hypothesis Testing and Dynamic Treatment Regimes S.A. Murphy Schering-Plough Workshop May 2007 TexPoint fonts used in EMF. Read the TexPoint manual before.
An Experimental Paradigm for Developing Adaptive Treatment Strategies S.A. Murphy Univ. of Michigan UNC: November, 2003.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan PSU, October, 2005 In Honor of Clifford C. Clogg.
Statistical Issues in Developing Adaptive Treatment Strategies for Chronic Disorders S.A. Murphy Univ. of Michigan CDC/ATSDR: March, 2005.
Hypothesis Testing and Dynamic Treatment Regimes S.A. Murphy, L. Gunter & B. Chakraborty ENAR March 2007.
1 SMART Designs for Developing Adaptive Treatment Strategies S.A. Murphy K. Lynch, J. McKay, D. Oslin & T.Ten Have UMichSpline February, 2006.
A Finite Sample Upper Bound on the Generalization Error for Q-Learning S.A. Murphy Univ. of Michigan CALD: February, 2005.
Methodology for Adaptive Treatment Strategies R21 DA S.A. Murphy For MCATS Oct. 8, 2009.
An Experimental Paradigm for Developing Adaptive Treatment Strategies S.A. Murphy Univ. of Michigan ACSIR, July, 2003.
An Experimental Paradigm for Developing Adaptive Treatment Strategies S.A. Murphy Univ. of Michigan February, 2004.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan Yale: November, 2005.
Methods for Estimating the Decision Rules in Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan IBC/ASC: July, 2004.
1 Possible Roles for Reinforcement Learning in Clinical Research S.A. Murphy November 14, 2007.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan April, 2006.
SMART Experimental Designs for Developing Adaptive Treatment Strategies S.A. Murphy ISCTM, 2007.
1 Section IV Study Designs for Investigating Adaptive Treatment Strategies Murphy.
Experiments and Adaptive Treatment Strategies S.A. Murphy Univ. of Michigan Chicago: May, 2005.
Susan Murphy, PI University of Michigan Acknowledgements: MCAT network and NIH The Goal To facilitate methodological collaborations necessary for producing.
Variable Selection for Optimal Decision Making Susan Murphy & Lacey Gunter University of Michigan Statistics Department Artificial Intelligence Seminar.
Clinical Trials Hanyan Yang
1 Dynamic Treatment Regimes: Interventions for Chronic Conditions (such as Poverty or Criminality?) S.A. Murphy Univ. of Michigan In Honor of Clifford.
SMART Designs for Developing Dynamic Treatment Regimes S.A. Murphy Symposium on Causal Inference Johns Hopkins, January, 2006.
Experiments and Dynamic Treatment Regimes S.A. Murphy At NIAID, BRB December, 2007.
1 Machine/Reinforcement Learning in Clinical Research S.A. Murphy May 19, 2008.
Adaptive Treatment Strategies S.A. Murphy CCNIA Proposal Meeting 2008.
Adaptive Treatment Strategies S.A. Murphy Workshop on Adaptive Treatment Strategies Convergence, 2008.
Practical Application of Adaptive Treatment Strategies in Trial Design and Analysis S.A. Murphy Center for Clinical Trials Network Classroom Series April.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan January, 2006.
Variable Selection for Optimal Decision Making Lacey Gunter University of Michigan Statistics Department Michigan Student Symposium for Interdisciplinary.
1 Variable Selection for Tailoring Treatment S.A. Murphy, L. Gunter & J. Zhu May 29, 2008.
Hypothesis Testing and Adaptive Treatment Strategies S.A. Murphy SCT May 2007.
Adaptive Treatment Strategies: Challenges in Data Analysis S.A. Murphy NY State Psychiatric Institute February, 2009.
Challenges and Successes Treating Adolescent Substance Use Disorders Janet L. Brody, Ph.D. Center for Family and Adolescent Research (CFAR), Oregon Research.
Introduction to the design (and analysis) of experiments James M. Curran Department of Statistics, University of Auckland
Sequential, Multiple Assignment, Randomized Trials and Treatment Policies S.A. Murphy UAlberta, 09/28/12 TexPoint fonts used in EMF. Read the TexPoint.
Stat Club 327 Thomas February 18, 2015 Bethany C. Bray Outreach Director, The Methodology Center Research Assistant Professor, College of HHD.
Self-reported cognitive and emotional effects and lifestyle changes shortly after preventive cardiovascular consultations in general practice Dea Kehler.
Sequential, Multiple Assignment, Randomized Trials and Treatment Policies S.A. Murphy MUCMD, 08/10/12 TexPoint fonts used in EMF. Read the TexPoint manual.
Research Study Design. Objective- To devise a study method that will clearly answer the study question with the least amount of time, energy, cost, and.
Sequential, Multiple Assignment, Randomized Trials Module 2—Day 1 Getting SMART About Developing Individualized Adaptive Health Interventions Methods Work,
Copyright © 2013, 2009, and 2007, Pearson Education, Inc. Chapter 4 Gathering Data Section 4.3 Good and Poor Ways to Experiment.
SS440 Seminar: Unit 4 Research in Psychopathology Dr. Angie Whalen Kaplan University 1.
Study Session Experimental Design. 1. Which of the following is true regarding the difference between an observational study and and an experiment? a)
1 SMART Designs for Developing Adaptive Treatment Strategies S.A. Murphy K. Lynch, J. McKay, D. Oslin & T.Ten Have NDRI April, 2006.
Motivation Using SMART research designs to improve individualized treatments Alena Scott 1, Janet Levy 3, and Susan Murphy 1,2 Institute for Social Research.
An Experimental Paradigm for Developing Adaptive Treatment Strategies S.A. Murphy NIDA Meeting on Treatment and Recovery Processes January, 2004.
Experimental and Ex Post Facto Designs
Designing An Adaptive Treatment Susan A. Murphy Univ. of Michigan Joint with Linda Collins & Karen Bierman Pennsylvania State Univ.
Abstract VARIABLE SELECTION FOR DECISION MAKING IN MENTAL HEALTH Lacey Gunter 1,2, Ji Zhu 1, and Susan Murphy 1,2 Departments of Statistics 1 and Institute.
SMART Trials for Developing Adaptive Treatment Strategies S.A. Murphy Workshop on Adaptive Treatment Designs NCDEU, 2006.
Introduction to the design (and analysis) of experiments
Secondary outcomes in pharmacological and behavioral treatment trials standardized or tailored to intervention type? Kevin M. Gray, M.D. Professor and.
Presentation transcript:

Michigan Team February, 2005

Amy Wagaman Bibhas Chakraborty Herle McGowan Susan Murphy Lacey Gunter Danny Almirall Anne Buu

Outline Overview Danny Almirall Anne Buu Bibhas Chakraborty Lacey Gunter Herle McGowan Susan Murphy Amy Wagaman New Additions!

Primary Focus Drug Dependence Prevention and Treatment Time-varying Treatments Development of Designs and Methodology that informs the construction of adaptive treatment strategies. –Chronic, relapsing disorder requires sequencing and timing decisions –High dimensional problems –Treatments are multi-component

Danny Almirall Structural Nested Mean Models for Assessing Time-Varying Effect Moderation Danny’s research is funded by a Rackham Fellowship; collaborates with Tom Ten Have and Susan.

Effect Moderation Two time points: S 1, a 1, S 2 (a 1 ), a 2, Y(a 1, a 2 ). a’s are time-varying treatments; S’s are time- varying observations; Y is response. –  2 (a 2,s 2 )=effect of treatment a 2 on response Y(a 1,.) given S 1 =s 1, S 2 (a 1 )=s 2. –  1 (a 1,s 1 )=effect of treatment a 1 on response, Y(.,0), given S 1 =s 1.  1 and  2 describe the intermediate effects of a 1 and a 2, respectively, given the past. They describe time-varying effect moderation. No effect moderation   ’s are constant in S’s.

The Structural Nested Mean Model The SNMM provides a way to combine  1 and  2 in a model for the conditional mean of Y(a 1,a 2 ) given S 1 and S 2 (a 1 ). One can then pose parametric models for  1 and  2. The challenge is that the SNMM depends, additionally, on non-causal nuisance functions related to the “main effects” of the S’s.

Estimating the SNMM Semi-parametric estimators exist that do not require positing models for the nuisance functions, but are they too variable? Estimators that include models for the nuisance functions may be less variable. But positing mis-specified models for the nuisance function may induce bias in the estimates of the treatment effects. We wish to study the bias-variance tradeoff.

Anne Buu Beginning work on a K01 application to NIDA Anne’s research is funded by Bob Zucker in the Psychiatry Department

Ideas so far Use smoothing techniques to analyze data from the University of Michigan-Michigan State Longitudinal Family Study. (Use functional data analyses and also ideas by Rice in 2004.) Construct child development profiles by family types Model impact of family factors on child development profiles

U of M-MSU Family Study An eighteen year prospective study Each family was recruited as a triad: alcoholic father, biological mother and 3-5 year old son. Each member was assessed on psychological, social, cognitive, and substance use every 3 years. During adolescence (ages 11-18), the target son was assessed annually. At later time points, siblings were also assessed.

Bibhas Chakraborty Design Strategies for Behavioral Intervention Research: A Simulation Study Bibhas’ research is funded by Vic Strecher’s NCI P-50; Collaborates with Vijay Nair, Vic Strecher, Linda Collins and Susan.

The Goal Evaluate Designs for optimizing a multi- component behavioral treatment. In the present study, we are comparing the classical randomized trial approach vs. multistage experimental approach (MOST using balanced fractional factorials). We want to identify situations where one approach is distinctly better than the other.

The Set-up / Simulation Design The true data-generating model is a complete mediation model, with 6 factors, 6 adherence variables, 6 mediators and the response. Unknown component: Type (binary). All but one factors are binary. Use of scientist’s prior knowledge in both classical and experimental approach.

The Classical Approach Two-group comparison of treatment vs. control (Kitchen-sink approach) on the entire set of subjects. Post hoc analysis to: - investigate the reason of insignificance. - refine the significant treatment combination. Post hoc analysis is either dose-response analysis or regression with mediators as intermediate outcome.

The Experimental Approach Divide available subjects into two groups and conduct two experimental stages: Screening and Refining. Screening Stage: Use Fractional Factorial Design to estimate main effects and interactions. Refining Stage: - Finding best level of a non-binary factor. - Settling confusion about significant (aliased) interactions, if necessary. Thus optimizing treatment proactively

Lacey Gunter Comparing Reinforcement Learning Algorithms Lacey’s research is funded by this center; she works with Susan.

Reinforcement Learning What is it? Learning through interaction with your environment The general idea: Based on present information and past experience, our goal is to choose actions which achieve the best long term results Example: Based on past adherence and responses to treatment and the current health status of a patient, what actions should we take to minimize a patient’s long term drug dependence.

Reinforcement Learning Algorithms Several algorithms exist for choosing the best set of actions, we are studying two such algorithms Q-learning: model outcome based on past experience, current action and the interaction between past experience and current action A-learning: model outcome only based on current action and the interaction between past experience and current action

We conjecture: Q-learning tends to be more biased but less variable A-learning tends to be less biased but more variable We are studying which algorithm performs better in terms of bias-variance trade off in different settings These tradeoffs are altered when we use bagging.

Herle McGowan Causal Inference & Data Collection Herle’s research is funded by this center; she collaborates with Rob Nix, Karen Bierman and Susan.

Data Collection Data collection methods involving clinical judgment that can result in confounding Data collection using a regression discontinuity design combined with clinical judgment

Using clinical judgment to readjust dose throughout trial Causes confounding when we want to run a dose response. Currently Herle is writing a paper discussing this issue and illustrating the kinds of biases that can occur.

Regression Discontinuity Regression discontinuity (RD) design. –All subjects scoring above a cutoff value are assigned to one treatment condition while all subjects scoring below are assigned to a second treatment condition.

Regression Discontinuity Designs & Clinical Judgment Herle’s thesis will be on this topic; she has already completed much of the literature review and background work.

Susan Murphy Experimental Design and Analysis Methods for Developing Adaptive Treatment Strategies Susan’s research is funded by this center, a K02, an R21 & Vic Strecher’s P-50.

Projects Experimental designs for developing treatment strategies with Derek Bingham and Linda Collins Formulating less biased methods for constructing treatment strategies. Using system dynamics models to inform the construction of treatment strategies with Joelle Pineau, John Rush and Satinder Baveja.

Projects Working on a white paper concerning the methodological challenges in developing treatment strategies with Dave Oslin, John Rush and Satinder Baveja. Writing a grant (right now) with Vic Strecher, Caroline Richardson and Satinder Baveja to develop a prevention program designed to increase and maintain activity.

Amy Wagaman Constructing Tailoring Variables for Decision Making Amy’s research is funded by this center; she collaborates with Jim McKay, Ji Zhu and Susan.

Developing a Tailoring Variable The primary objective is to develop a summary variable that can discriminate between patients in terms of assigning a treatment. This summary variable is constructed from individual characteristics and behavior on past treatment. Tools are PLS and combining this with binary responses.

Motivation Consider a substance abuse aftercare program, where the goal is to prevent patient relapse. Assume that there is a treatment effect, and a treatment interaction with a variable that measures counseling attendance during prior acute treatment. Perhaps highly motivated patients would benefit more from one treatment on average, while patients with low motivation would benefit more from another.

Challenges The summary variable must be constructed from data that lives in a high dimensional space, i.e. dimension reduction methods need to be used. Subject-based knowledge about what variables might be more useful should be taken into account. There is a danger that detected interactions may be spurious.

Additions! Pawel Mierzejewski (beginning work with Satinder Baveja, John Rush and Susan on feature construction)